- Home
- VCEL vs UAMY Comparison
VCEL vs UAMY Comparison
Compare VCEL & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | UAMY |
|---|---|---|
| Founded | 1989 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 1997 |
Fundamental Metrics
Financial Performance| Metric | VCEL | UAMY |
|---|---|---|
| Price | $46.23 | $6.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $57.75 | $9.44 |
| AVG Volume (30 Days) | 598.5K | ★ 8.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | $39,257,708.00 |
| Revenue This Year | $19.40 | $219.89 |
| Revenue Next Year | $18.24 | $104.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 16.45 | ★ 162.80 |
| 52 Week Low | $28.95 | $1.94 |
| 52 Week High | $43.57 | $19.71 |
Technical Indicators
Market Signals| Indicator | VCEL | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 81.81 | 39.09 |
| Support Level | $32.47 | $5.87 |
| Resistance Level | N/A | $6.95 |
| Average True Range (ATR) | 1.61 | 0.56 |
| MACD | 0.70 | -0.03 |
| Stochastic Oscillator | 96.76 | 24.57 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.